Global Biotechnological Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Biotechnological Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Biotechnological Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biotechnological Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biotechnological Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biotechnological Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biotechnological Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biotechnological Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biotechnological Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3SBIO, Anhui Anke Biotechnology, Beijing SL Pharmaceutical, Biotech Pharmaceutical and Cadila Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biotechnological Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Biotechnological Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biotechnological Drugs, with revenue, gross margin and global market share of Biotechnological Drugs from 2018 to 2023.
Chapter 3, the Biotechnological Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biotechnological Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biotechnological Drugs.
Chapter 13, to describe Biotechnological Drugs research findings and conclusion.
This report is a detailed and comprehensive analysis for global Biotechnological Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biotechnological Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biotechnological Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biotechnological Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biotechnological Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biotechnological Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biotechnological Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3SBIO, Anhui Anke Biotechnology, Beijing SL Pharmaceutical, Biotech Pharmaceutical and Cadila Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biotechnological Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Genetically Engineered Drugs
- Therapeutic Monoclonal Antibody Drugs
- Gene Therapy and Nucleic Acid Drugs
- Genetically Engineered Vaccines
- Other
- Tumor
- Autoimmune Disease
- Other
- 3SBIO
- Anhui Anke Biotechnology
- Beijing SL Pharmaceutical
- Biotech Pharmaceutical
- Cadila Healthcare
- Celgen Biopharma
- Celltrion
- Dr Reddy’s
- GeneScience Pharmaceuticals
- Hisun Pharma
- Jiangsu Sihuan Bioengineering
- Novartis (Sandoz)
- Pfizer (Hospira)
- Shanghai Lansheng Guojian Pharmaceutical
- Shenzhen Neptunus Interlong Bio-Technique
- Tonghua Dongbao Pharmaceutical
- Torrent Pharmaceuticals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biotechnological Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biotechnological Drugs, with revenue, gross margin and global market share of Biotechnological Drugs from 2018 to 2023.
Chapter 3, the Biotechnological Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biotechnological Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biotechnological Drugs.
Chapter 13, to describe Biotechnological Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biotechnological Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biotechnological Drugs by Type
1.3.1 Overview: Global Biotechnological Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biotechnological Drugs Consumption Value Market Share by Type in 2022
1.3.3 Genetically Engineered Drugs
1.3.4 Therapeutic Monoclonal Antibody Drugs
1.3.5 Gene Therapy and Nucleic Acid Drugs
1.3.6 Genetically Engineered Vaccines
1.3.7 Other
1.4 Global Biotechnological Drugs Market by Application
1.4.1 Overview: Global Biotechnological Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tumor
1.4.3 Autoimmune Disease
1.4.4 Other
1.5 Global Biotechnological Drugs Market Size & Forecast
1.6 Global Biotechnological Drugs Market Size and Forecast by Region
1.6.1 Global Biotechnological Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biotechnological Drugs Market Size by Region, (2018-2029)
1.6.3 North America Biotechnological Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Biotechnological Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biotechnological Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Biotechnological Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biotechnological Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 3SBIO
2.1.1 3SBIO Details
2.1.2 3SBIO Major Business
2.1.3 3SBIO Biotechnological Drugs Product and Solutions
2.1.4 3SBIO Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 3SBIO Recent Developments and Future Plans
2.2 Anhui Anke Biotechnology
2.2.1 Anhui Anke Biotechnology Details
2.2.2 Anhui Anke Biotechnology Major Business
2.2.3 Anhui Anke Biotechnology Biotechnological Drugs Product and Solutions
2.2.4 Anhui Anke Biotechnology Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Anhui Anke Biotechnology Recent Developments and Future Plans
2.3 Beijing SL Pharmaceutical
2.3.1 Beijing SL Pharmaceutical Details
2.3.2 Beijing SL Pharmaceutical Major Business
2.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Product and Solutions
2.3.4 Beijing SL Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing SL Pharmaceutical Recent Developments and Future Plans
2.4 Biotech Pharmaceutical
2.4.1 Biotech Pharmaceutical Details
2.4.2 Biotech Pharmaceutical Major Business
2.4.3 Biotech Pharmaceutical Biotechnological Drugs Product and Solutions
2.4.4 Biotech Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Biotech Pharmaceutical Recent Developments and Future Plans
2.5 Cadila Healthcare
2.5.1 Cadila Healthcare Details
2.5.2 Cadila Healthcare Major Business
2.5.3 Cadila Healthcare Biotechnological Drugs Product and Solutions
2.5.4 Cadila Healthcare Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cadila Healthcare Recent Developments and Future Plans
2.6 Celgen Biopharma
2.6.1 Celgen Biopharma Details
2.6.2 Celgen Biopharma Major Business
2.6.3 Celgen Biopharma Biotechnological Drugs Product and Solutions
2.6.4 Celgen Biopharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Celgen Biopharma Recent Developments and Future Plans
2.7 Celltrion
2.7.1 Celltrion Details
2.7.2 Celltrion Major Business
2.7.3 Celltrion Biotechnological Drugs Product and Solutions
2.7.4 Celltrion Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Celltrion Recent Developments and Future Plans
2.8 Dr Reddy’s
2.8.1 Dr Reddy’s Details
2.8.2 Dr Reddy’s Major Business
2.8.3 Dr Reddy’s Biotechnological Drugs Product and Solutions
2.8.4 Dr Reddy’s Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Dr Reddy’s Recent Developments and Future Plans
2.9 GeneScience Pharmaceuticals
2.9.1 GeneScience Pharmaceuticals Details
2.9.2 GeneScience Pharmaceuticals Major Business
2.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Product and Solutions
2.9.4 GeneScience Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GeneScience Pharmaceuticals Recent Developments and Future Plans
2.10 Hisun Pharma
2.10.1 Hisun Pharma Details
2.10.2 Hisun Pharma Major Business
2.10.3 Hisun Pharma Biotechnological Drugs Product and Solutions
2.10.4 Hisun Pharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hisun Pharma Recent Developments and Future Plans
2.11 Jiangsu Sihuan Bioengineering
2.11.1 Jiangsu Sihuan Bioengineering Details
2.11.2 Jiangsu Sihuan Bioengineering Major Business
2.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product and Solutions
2.11.4 Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Jiangsu Sihuan Bioengineering Recent Developments and Future Plans
2.12 Novartis (Sandoz)
2.12.1 Novartis (Sandoz) Details
2.12.2 Novartis (Sandoz) Major Business
2.12.3 Novartis (Sandoz) Biotechnological Drugs Product and Solutions
2.12.4 Novartis (Sandoz) Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Novartis (Sandoz) Recent Developments and Future Plans
2.13 Pfizer (Hospira)
2.13.1 Pfizer (Hospira) Details
2.13.2 Pfizer (Hospira) Major Business
2.13.3 Pfizer (Hospira) Biotechnological Drugs Product and Solutions
2.13.4 Pfizer (Hospira) Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pfizer (Hospira) Recent Developments and Future Plans
2.14 Shanghai Lansheng Guojian Pharmaceutical
2.14.1 Shanghai Lansheng Guojian Pharmaceutical Details
2.14.2 Shanghai Lansheng Guojian Pharmaceutical Major Business
2.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product and Solutions
2.14.4 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments and Future Plans
2.15 Shenzhen Neptunus Interlong Bio-Technique
2.15.1 Shenzhen Neptunus Interlong Bio-Technique Details
2.15.2 Shenzhen Neptunus Interlong Bio-Technique Major Business
2.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product and Solutions
2.15.4 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments and Future Plans
2.16 Tonghua Dongbao Pharmaceutical
2.16.1 Tonghua Dongbao Pharmaceutical Details
2.16.2 Tonghua Dongbao Pharmaceutical Major Business
2.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product and Solutions
2.16.4 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Tonghua Dongbao Pharmaceutical Recent Developments and Future Plans
2.17 Torrent Pharmaceuticals
2.17.1 Torrent Pharmaceuticals Details
2.17.2 Torrent Pharmaceuticals Major Business
2.17.3 Torrent Pharmaceuticals Biotechnological Drugs Product and Solutions
2.17.4 Torrent Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Torrent Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biotechnological Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biotechnological Drugs by Company Revenue
3.2.2 Top 3 Biotechnological Drugs Players Market Share in 2022
3.2.3 Top 6 Biotechnological Drugs Players Market Share in 2022
3.3 Biotechnological Drugs Market: Overall Company Footprint Analysis
3.3.1 Biotechnological Drugs Market: Region Footprint
3.3.2 Biotechnological Drugs Market: Company Product Type Footprint
3.3.3 Biotechnological Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biotechnological Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biotechnological Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biotechnological Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Biotechnological Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biotechnological Drugs Consumption Value by Type (2018-2029)
6.2 North America Biotechnological Drugs Consumption Value by Application (2018-2029)
6.3 North America Biotechnological Drugs Market Size by Country
6.3.1 North America Biotechnological Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Biotechnological Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Biotechnological Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Biotechnological Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biotechnological Drugs Consumption Value by Type (2018-2029)
7.2 Europe Biotechnological Drugs Consumption Value by Application (2018-2029)
7.3 Europe Biotechnological Drugs Market Size by Country
7.3.1 Europe Biotechnological Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Biotechnological Drugs Market Size and Forecast (2018-2029)
7.3.3 France Biotechnological Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biotechnological Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Biotechnological Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Biotechnological Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biotechnological Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biotechnological Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biotechnological Drugs Market Size by Region
8.3.1 Asia-Pacific Biotechnological Drugs Consumption Value by Region (2018-2029)
8.3.2 China Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.5 India Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Biotechnological Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biotechnological Drugs Consumption Value by Type (2018-2029)
9.2 South America Biotechnological Drugs Consumption Value by Application (2018-2029)
9.3 South America Biotechnological Drugs Market Size by Country
9.3.1 South America Biotechnological Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Biotechnological Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Biotechnological Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biotechnological Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biotechnological Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biotechnological Drugs Market Size by Country
10.3.1 Middle East & Africa Biotechnological Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Biotechnological Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biotechnological Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Biotechnological Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biotechnological Drugs Market Drivers
11.2 Biotechnological Drugs Market Restraints
11.3 Biotechnological Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biotechnological Drugs Industry Chain
12.2 Biotechnological Drugs Upstream Analysis
12.3 Biotechnological Drugs Midstream Analysis
12.4 Biotechnological Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biotechnological Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biotechnological Drugs by Type
1.3.1 Overview: Global Biotechnological Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biotechnological Drugs Consumption Value Market Share by Type in 2022
1.3.3 Genetically Engineered Drugs
1.3.4 Therapeutic Monoclonal Antibody Drugs
1.3.5 Gene Therapy and Nucleic Acid Drugs
1.3.6 Genetically Engineered Vaccines
1.3.7 Other
1.4 Global Biotechnological Drugs Market by Application
1.4.1 Overview: Global Biotechnological Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tumor
1.4.3 Autoimmune Disease
1.4.4 Other
1.5 Global Biotechnological Drugs Market Size & Forecast
1.6 Global Biotechnological Drugs Market Size and Forecast by Region
1.6.1 Global Biotechnological Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biotechnological Drugs Market Size by Region, (2018-2029)
1.6.3 North America Biotechnological Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Biotechnological Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biotechnological Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Biotechnological Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biotechnological Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 3SBIO
2.1.1 3SBIO Details
2.1.2 3SBIO Major Business
2.1.3 3SBIO Biotechnological Drugs Product and Solutions
2.1.4 3SBIO Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 3SBIO Recent Developments and Future Plans
2.2 Anhui Anke Biotechnology
2.2.1 Anhui Anke Biotechnology Details
2.2.2 Anhui Anke Biotechnology Major Business
2.2.3 Anhui Anke Biotechnology Biotechnological Drugs Product and Solutions
2.2.4 Anhui Anke Biotechnology Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Anhui Anke Biotechnology Recent Developments and Future Plans
2.3 Beijing SL Pharmaceutical
2.3.1 Beijing SL Pharmaceutical Details
2.3.2 Beijing SL Pharmaceutical Major Business
2.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Product and Solutions
2.3.4 Beijing SL Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing SL Pharmaceutical Recent Developments and Future Plans
2.4 Biotech Pharmaceutical
2.4.1 Biotech Pharmaceutical Details
2.4.2 Biotech Pharmaceutical Major Business
2.4.3 Biotech Pharmaceutical Biotechnological Drugs Product and Solutions
2.4.4 Biotech Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Biotech Pharmaceutical Recent Developments and Future Plans
2.5 Cadila Healthcare
2.5.1 Cadila Healthcare Details
2.5.2 Cadila Healthcare Major Business
2.5.3 Cadila Healthcare Biotechnological Drugs Product and Solutions
2.5.4 Cadila Healthcare Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cadila Healthcare Recent Developments and Future Plans
2.6 Celgen Biopharma
2.6.1 Celgen Biopharma Details
2.6.2 Celgen Biopharma Major Business
2.6.3 Celgen Biopharma Biotechnological Drugs Product and Solutions
2.6.4 Celgen Biopharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Celgen Biopharma Recent Developments and Future Plans
2.7 Celltrion
2.7.1 Celltrion Details
2.7.2 Celltrion Major Business
2.7.3 Celltrion Biotechnological Drugs Product and Solutions
2.7.4 Celltrion Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Celltrion Recent Developments and Future Plans
2.8 Dr Reddy’s
2.8.1 Dr Reddy’s Details
2.8.2 Dr Reddy’s Major Business
2.8.3 Dr Reddy’s Biotechnological Drugs Product and Solutions
2.8.4 Dr Reddy’s Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Dr Reddy’s Recent Developments and Future Plans
2.9 GeneScience Pharmaceuticals
2.9.1 GeneScience Pharmaceuticals Details
2.9.2 GeneScience Pharmaceuticals Major Business
2.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Product and Solutions
2.9.4 GeneScience Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GeneScience Pharmaceuticals Recent Developments and Future Plans
2.10 Hisun Pharma
2.10.1 Hisun Pharma Details
2.10.2 Hisun Pharma Major Business
2.10.3 Hisun Pharma Biotechnological Drugs Product and Solutions
2.10.4 Hisun Pharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hisun Pharma Recent Developments and Future Plans
2.11 Jiangsu Sihuan Bioengineering
2.11.1 Jiangsu Sihuan Bioengineering Details
2.11.2 Jiangsu Sihuan Bioengineering Major Business
2.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product and Solutions
2.11.4 Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Jiangsu Sihuan Bioengineering Recent Developments and Future Plans
2.12 Novartis (Sandoz)
2.12.1 Novartis (Sandoz) Details
2.12.2 Novartis (Sandoz) Major Business
2.12.3 Novartis (Sandoz) Biotechnological Drugs Product and Solutions
2.12.4 Novartis (Sandoz) Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Novartis (Sandoz) Recent Developments and Future Plans
2.13 Pfizer (Hospira)
2.13.1 Pfizer (Hospira) Details
2.13.2 Pfizer (Hospira) Major Business
2.13.3 Pfizer (Hospira) Biotechnological Drugs Product and Solutions
2.13.4 Pfizer (Hospira) Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pfizer (Hospira) Recent Developments and Future Plans
2.14 Shanghai Lansheng Guojian Pharmaceutical
2.14.1 Shanghai Lansheng Guojian Pharmaceutical Details
2.14.2 Shanghai Lansheng Guojian Pharmaceutical Major Business
2.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product and Solutions
2.14.4 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments and Future Plans
2.15 Shenzhen Neptunus Interlong Bio-Technique
2.15.1 Shenzhen Neptunus Interlong Bio-Technique Details
2.15.2 Shenzhen Neptunus Interlong Bio-Technique Major Business
2.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product and Solutions
2.15.4 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments and Future Plans
2.16 Tonghua Dongbao Pharmaceutical
2.16.1 Tonghua Dongbao Pharmaceutical Details
2.16.2 Tonghua Dongbao Pharmaceutical Major Business
2.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product and Solutions
2.16.4 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Tonghua Dongbao Pharmaceutical Recent Developments and Future Plans
2.17 Torrent Pharmaceuticals
2.17.1 Torrent Pharmaceuticals Details
2.17.2 Torrent Pharmaceuticals Major Business
2.17.3 Torrent Pharmaceuticals Biotechnological Drugs Product and Solutions
2.17.4 Torrent Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Torrent Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biotechnological Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biotechnological Drugs by Company Revenue
3.2.2 Top 3 Biotechnological Drugs Players Market Share in 2022
3.2.3 Top 6 Biotechnological Drugs Players Market Share in 2022
3.3 Biotechnological Drugs Market: Overall Company Footprint Analysis
3.3.1 Biotechnological Drugs Market: Region Footprint
3.3.2 Biotechnological Drugs Market: Company Product Type Footprint
3.3.3 Biotechnological Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biotechnological Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biotechnological Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biotechnological Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Biotechnological Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biotechnological Drugs Consumption Value by Type (2018-2029)
6.2 North America Biotechnological Drugs Consumption Value by Application (2018-2029)
6.3 North America Biotechnological Drugs Market Size by Country
6.3.1 North America Biotechnological Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Biotechnological Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Biotechnological Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Biotechnological Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biotechnological Drugs Consumption Value by Type (2018-2029)
7.2 Europe Biotechnological Drugs Consumption Value by Application (2018-2029)
7.3 Europe Biotechnological Drugs Market Size by Country
7.3.1 Europe Biotechnological Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Biotechnological Drugs Market Size and Forecast (2018-2029)
7.3.3 France Biotechnological Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biotechnological Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Biotechnological Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Biotechnological Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biotechnological Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biotechnological Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biotechnological Drugs Market Size by Region
8.3.1 Asia-Pacific Biotechnological Drugs Consumption Value by Region (2018-2029)
8.3.2 China Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.5 India Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biotechnological Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Biotechnological Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biotechnological Drugs Consumption Value by Type (2018-2029)
9.2 South America Biotechnological Drugs Consumption Value by Application (2018-2029)
9.3 South America Biotechnological Drugs Market Size by Country
9.3.1 South America Biotechnological Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Biotechnological Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Biotechnological Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biotechnological Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biotechnological Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biotechnological Drugs Market Size by Country
10.3.1 Middle East & Africa Biotechnological Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Biotechnological Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biotechnological Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Biotechnological Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biotechnological Drugs Market Drivers
11.2 Biotechnological Drugs Market Restraints
11.3 Biotechnological Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biotechnological Drugs Industry Chain
12.2 Biotechnological Drugs Upstream Analysis
12.3 Biotechnological Drugs Midstream Analysis
12.4 Biotechnological Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biotechnological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biotechnological Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biotechnological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biotechnological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. 3SBIO Company Information, Head Office, and Major Competitors
Table 6. 3SBIO Major Business
Table 7. 3SBIO Biotechnological Drugs Product and Solutions
Table 8. 3SBIO Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. 3SBIO Recent Developments and Future Plans
Table 10. Anhui Anke Biotechnology Company Information, Head Office, and Major Competitors
Table 11. Anhui Anke Biotechnology Major Business
Table 12. Anhui Anke Biotechnology Biotechnological Drugs Product and Solutions
Table 13. Anhui Anke Biotechnology Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Anhui Anke Biotechnology Recent Developments and Future Plans
Table 15. Beijing SL Pharmaceutical Company Information, Head Office, and Major Competitors
Table 16. Beijing SL Pharmaceutical Major Business
Table 17. Beijing SL Pharmaceutical Biotechnological Drugs Product and Solutions
Table 18. Beijing SL Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Beijing SL Pharmaceutical Recent Developments and Future Plans
Table 20. Biotech Pharmaceutical Company Information, Head Office, and Major Competitors
Table 21. Biotech Pharmaceutical Major Business
Table 22. Biotech Pharmaceutical Biotechnological Drugs Product and Solutions
Table 23. Biotech Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Biotech Pharmaceutical Recent Developments and Future Plans
Table 25. Cadila Healthcare Company Information, Head Office, and Major Competitors
Table 26. Cadila Healthcare Major Business
Table 27. Cadila Healthcare Biotechnological Drugs Product and Solutions
Table 28. Cadila Healthcare Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Cadila Healthcare Recent Developments and Future Plans
Table 30. Celgen Biopharma Company Information, Head Office, and Major Competitors
Table 31. Celgen Biopharma Major Business
Table 32. Celgen Biopharma Biotechnological Drugs Product and Solutions
Table 33. Celgen Biopharma Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Celgen Biopharma Recent Developments and Future Plans
Table 35. Celltrion Company Information, Head Office, and Major Competitors
Table 36. Celltrion Major Business
Table 37. Celltrion Biotechnological Drugs Product and Solutions
Table 38. Celltrion Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Celltrion Recent Developments and Future Plans
Table 40. Dr Reddy’s Company Information, Head Office, and Major Competitors
Table 41. Dr Reddy’s Major Business
Table 42. Dr Reddy’s Biotechnological Drugs Product and Solutions
Table 43. Dr Reddy’s Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Dr Reddy’s Recent Developments and Future Plans
Table 45. GeneScience Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. GeneScience Pharmaceuticals Major Business
Table 47. GeneScience Pharmaceuticals Biotechnological Drugs Product and Solutions
Table 48. GeneScience Pharmaceuticals Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. GeneScience Pharmaceuticals Recent Developments and Future Plans
Table 50. Hisun Pharma Company Information, Head Office, and Major Competitors
Table 51. Hisun Pharma Major Business
Table 52. Hisun Pharma Biotechnological Drugs Product and Solutions
Table 53. Hisun Pharma Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Hisun Pharma Recent Developments and Future Plans
Table 55. Jiangsu Sihuan Bioengineering Company Information, Head Office, and Major Competitors
Table 56. Jiangsu Sihuan Bioengineering Major Business
Table 57. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product and Solutions
Table 58. Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Jiangsu Sihuan Bioengineering Recent Developments and Future Plans
Table 60. Novartis (Sandoz) Company Information, Head Office, and Major Competitors
Table 61. Novartis (Sandoz) Major Business
Table 62. Novartis (Sandoz) Biotechnological Drugs Product and Solutions
Table 63. Novartis (Sandoz) Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Novartis (Sandoz) Recent Developments and Future Plans
Table 65. Pfizer (Hospira) Company Information, Head Office, and Major Competitors
Table 66. Pfizer (Hospira) Major Business
Table 67. Pfizer (Hospira) Biotechnological Drugs Product and Solutions
Table 68. Pfizer (Hospira) Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Pfizer (Hospira) Recent Developments and Future Plans
Table 70. Shanghai Lansheng Guojian Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. Shanghai Lansheng Guojian Pharmaceutical Major Business
Table 72. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product and Solutions
Table 73. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Shanghai Lansheng Guojian Pharmaceutical Recent Developments and Future Plans
Table 75. Shenzhen Neptunus Interlong Bio-Technique Company Information, Head Office, and Major Competitors
Table 76. Shenzhen Neptunus Interlong Bio-Technique Major Business
Table 77. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product and Solutions
Table 78. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Shenzhen Neptunus Interlong Bio-Technique Recent Developments and Future Plans
Table 80. Tonghua Dongbao Pharmaceutical Company Information, Head Office, and Major Competitors
Table 81. Tonghua Dongbao Pharmaceutical Major Business
Table 82. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product and Solutions
Table 83. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Tonghua Dongbao Pharmaceutical Recent Developments and Future Plans
Table 85. Torrent Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 86. Torrent Pharmaceuticals Major Business
Table 87. Torrent Pharmaceuticals Biotechnological Drugs Product and Solutions
Table 88. Torrent Pharmaceuticals Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Torrent Pharmaceuticals Recent Developments and Future Plans
Table 90. Global Biotechnological Drugs Revenue (USD Million) by Players (2018-2023)
Table 91. Global Biotechnological Drugs Revenue Share by Players (2018-2023)
Table 92. Breakdown of Biotechnological Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Biotechnological Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Biotechnological Drugs Players
Table 95. Biotechnological Drugs Market: Company Product Type Footprint
Table 96. Biotechnological Drugs Market: Company Product Application Footprint
Table 97. Biotechnological Drugs New Market Entrants and Barriers to Market Entry
Table 98. Biotechnological Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Biotechnological Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Biotechnological Drugs Consumption Value Share by Type (2018-2023)
Table 101. Global Biotechnological Drugs Consumption Value Forecast by Type (2024-2029)
Table 102. Global Biotechnological Drugs Consumption Value by Application (2018-2023)
Table 103. Global Biotechnological Drugs Consumption Value Forecast by Application (2024-2029)
Table 104. North America Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Biotechnological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Biotechnological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Biotechnological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Biotechnological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Biotechnological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Biotechnological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Biotechnological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Biotechnological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Biotechnological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Biotechnological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Biotechnological Drugs Raw Material
Table 135. Key Suppliers of Biotechnological Drugs Raw Materials
Table 1. Global Biotechnological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biotechnological Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biotechnological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biotechnological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. 3SBIO Company Information, Head Office, and Major Competitors
Table 6. 3SBIO Major Business
Table 7. 3SBIO Biotechnological Drugs Product and Solutions
Table 8. 3SBIO Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. 3SBIO Recent Developments and Future Plans
Table 10. Anhui Anke Biotechnology Company Information, Head Office, and Major Competitors
Table 11. Anhui Anke Biotechnology Major Business
Table 12. Anhui Anke Biotechnology Biotechnological Drugs Product and Solutions
Table 13. Anhui Anke Biotechnology Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Anhui Anke Biotechnology Recent Developments and Future Plans
Table 15. Beijing SL Pharmaceutical Company Information, Head Office, and Major Competitors
Table 16. Beijing SL Pharmaceutical Major Business
Table 17. Beijing SL Pharmaceutical Biotechnological Drugs Product and Solutions
Table 18. Beijing SL Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Beijing SL Pharmaceutical Recent Developments and Future Plans
Table 20. Biotech Pharmaceutical Company Information, Head Office, and Major Competitors
Table 21. Biotech Pharmaceutical Major Business
Table 22. Biotech Pharmaceutical Biotechnological Drugs Product and Solutions
Table 23. Biotech Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Biotech Pharmaceutical Recent Developments and Future Plans
Table 25. Cadila Healthcare Company Information, Head Office, and Major Competitors
Table 26. Cadila Healthcare Major Business
Table 27. Cadila Healthcare Biotechnological Drugs Product and Solutions
Table 28. Cadila Healthcare Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Cadila Healthcare Recent Developments and Future Plans
Table 30. Celgen Biopharma Company Information, Head Office, and Major Competitors
Table 31. Celgen Biopharma Major Business
Table 32. Celgen Biopharma Biotechnological Drugs Product and Solutions
Table 33. Celgen Biopharma Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Celgen Biopharma Recent Developments and Future Plans
Table 35. Celltrion Company Information, Head Office, and Major Competitors
Table 36. Celltrion Major Business
Table 37. Celltrion Biotechnological Drugs Product and Solutions
Table 38. Celltrion Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Celltrion Recent Developments and Future Plans
Table 40. Dr Reddy’s Company Information, Head Office, and Major Competitors
Table 41. Dr Reddy’s Major Business
Table 42. Dr Reddy’s Biotechnological Drugs Product and Solutions
Table 43. Dr Reddy’s Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Dr Reddy’s Recent Developments and Future Plans
Table 45. GeneScience Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. GeneScience Pharmaceuticals Major Business
Table 47. GeneScience Pharmaceuticals Biotechnological Drugs Product and Solutions
Table 48. GeneScience Pharmaceuticals Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. GeneScience Pharmaceuticals Recent Developments and Future Plans
Table 50. Hisun Pharma Company Information, Head Office, and Major Competitors
Table 51. Hisun Pharma Major Business
Table 52. Hisun Pharma Biotechnological Drugs Product and Solutions
Table 53. Hisun Pharma Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Hisun Pharma Recent Developments and Future Plans
Table 55. Jiangsu Sihuan Bioengineering Company Information, Head Office, and Major Competitors
Table 56. Jiangsu Sihuan Bioengineering Major Business
Table 57. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product and Solutions
Table 58. Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Jiangsu Sihuan Bioengineering Recent Developments and Future Plans
Table 60. Novartis (Sandoz) Company Information, Head Office, and Major Competitors
Table 61. Novartis (Sandoz) Major Business
Table 62. Novartis (Sandoz) Biotechnological Drugs Product and Solutions
Table 63. Novartis (Sandoz) Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Novartis (Sandoz) Recent Developments and Future Plans
Table 65. Pfizer (Hospira) Company Information, Head Office, and Major Competitors
Table 66. Pfizer (Hospira) Major Business
Table 67. Pfizer (Hospira) Biotechnological Drugs Product and Solutions
Table 68. Pfizer (Hospira) Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Pfizer (Hospira) Recent Developments and Future Plans
Table 70. Shanghai Lansheng Guojian Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. Shanghai Lansheng Guojian Pharmaceutical Major Business
Table 72. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product and Solutions
Table 73. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Shanghai Lansheng Guojian Pharmaceutical Recent Developments and Future Plans
Table 75. Shenzhen Neptunus Interlong Bio-Technique Company Information, Head Office, and Major Competitors
Table 76. Shenzhen Neptunus Interlong Bio-Technique Major Business
Table 77. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product and Solutions
Table 78. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Shenzhen Neptunus Interlong Bio-Technique Recent Developments and Future Plans
Table 80. Tonghua Dongbao Pharmaceutical Company Information, Head Office, and Major Competitors
Table 81. Tonghua Dongbao Pharmaceutical Major Business
Table 82. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product and Solutions
Table 83. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Tonghua Dongbao Pharmaceutical Recent Developments and Future Plans
Table 85. Torrent Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 86. Torrent Pharmaceuticals Major Business
Table 87. Torrent Pharmaceuticals Biotechnological Drugs Product and Solutions
Table 88. Torrent Pharmaceuticals Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Torrent Pharmaceuticals Recent Developments and Future Plans
Table 90. Global Biotechnological Drugs Revenue (USD Million) by Players (2018-2023)
Table 91. Global Biotechnological Drugs Revenue Share by Players (2018-2023)
Table 92. Breakdown of Biotechnological Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Biotechnological Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Biotechnological Drugs Players
Table 95. Biotechnological Drugs Market: Company Product Type Footprint
Table 96. Biotechnological Drugs Market: Company Product Application Footprint
Table 97. Biotechnological Drugs New Market Entrants and Barriers to Market Entry
Table 98. Biotechnological Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Biotechnological Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Biotechnological Drugs Consumption Value Share by Type (2018-2023)
Table 101. Global Biotechnological Drugs Consumption Value Forecast by Type (2024-2029)
Table 102. Global Biotechnological Drugs Consumption Value by Application (2018-2023)
Table 103. Global Biotechnological Drugs Consumption Value Forecast by Application (2024-2029)
Table 104. North America Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Biotechnological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Biotechnological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Biotechnological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Biotechnological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Biotechnological Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Biotechnological Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Biotechnological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Biotechnological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Biotechnological Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Biotechnological Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Biotechnological Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Biotechnological Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Biotechnological Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Biotechnological Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Biotechnological Drugs Raw Material
Table 135. Key Suppliers of Biotechnological Drugs Raw Materials
LIST OF FIGURES
Figure 1. Biotechnological Drugs Picture
Figure 2. Global Biotechnological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biotechnological Drugs Consumption Value Market Share by Type in 2022
Figure 4. Genetically Engineered Drugs
Figure 5. Therapeutic Monoclonal Antibody Drugs
Figure 6. Gene Therapy and Nucleic Acid Drugs
Figure 7. Genetically Engineered Vaccines
Figure 8. Other
Figure 9. Global Biotechnological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Biotechnological Drugs Consumption Value Market Share by Application in 2022
Figure 11. Tumor Picture
Figure 12. Autoimmune Disease Picture
Figure 13. Other Picture
Figure 14. Global Biotechnological Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Biotechnological Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Biotechnological Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Biotechnological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Biotechnological Drugs Consumption Value Market Share by Region in 2022
Figure 19. North America Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Biotechnological Drugs Revenue Share by Players in 2022
Figure 25. Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Biotechnological Drugs Market Share in 2022
Figure 27. Global Top 6 Players Biotechnological Drugs Market Share in 2022
Figure 28. Global Biotechnological Drugs Consumption Value Share by Type (2018-2023)
Figure 29. Global Biotechnological Drugs Market Share Forecast by Type (2024-2029)
Figure 30. Global Biotechnological Drugs Consumption Value Share by Application (2018-2023)
Figure 31. Global Biotechnological Drugs Market Share Forecast by Application (2024-2029)
Figure 32. North America Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Biotechnological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Biotechnological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. France Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Biotechnological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 49. China Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. India Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Biotechnological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Biotechnological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 66. Biotechnological Drugs Market Drivers
Figure 67. Biotechnological Drugs Market Restraints
Figure 68. Biotechnological Drugs Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Biotechnological Drugs in 2022
Figure 71. Manufacturing Process Analysis of Biotechnological Drugs
Figure 72. Biotechnological Drugs Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Biotechnological Drugs Picture
Figure 2. Global Biotechnological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biotechnological Drugs Consumption Value Market Share by Type in 2022
Figure 4. Genetically Engineered Drugs
Figure 5. Therapeutic Monoclonal Antibody Drugs
Figure 6. Gene Therapy and Nucleic Acid Drugs
Figure 7. Genetically Engineered Vaccines
Figure 8. Other
Figure 9. Global Biotechnological Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Biotechnological Drugs Consumption Value Market Share by Application in 2022
Figure 11. Tumor Picture
Figure 12. Autoimmune Disease Picture
Figure 13. Other Picture
Figure 14. Global Biotechnological Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Biotechnological Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Biotechnological Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Biotechnological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Biotechnological Drugs Consumption Value Market Share by Region in 2022
Figure 19. North America Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Biotechnological Drugs Revenue Share by Players in 2022
Figure 25. Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Biotechnological Drugs Market Share in 2022
Figure 27. Global Top 6 Players Biotechnological Drugs Market Share in 2022
Figure 28. Global Biotechnological Drugs Consumption Value Share by Type (2018-2023)
Figure 29. Global Biotechnological Drugs Market Share Forecast by Type (2024-2029)
Figure 30. Global Biotechnological Drugs Consumption Value Share by Application (2018-2023)
Figure 31. Global Biotechnological Drugs Market Share Forecast by Application (2024-2029)
Figure 32. North America Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Biotechnological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Biotechnological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. France Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Biotechnological Drugs Consumption Value Market Share by Region (2018-2029)
Figure 49. China Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. India Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Biotechnological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Biotechnological Drugs Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Biotechnological Drugs Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Biotechnological Drugs Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Biotechnological Drugs Consumption Value (2018-2029) & (USD Million)
Figure 66. Biotechnological Drugs Market Drivers
Figure 67. Biotechnological Drugs Market Restraints
Figure 68. Biotechnological Drugs Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Biotechnological Drugs in 2022
Figure 71. Manufacturing Process Analysis of Biotechnological Drugs
Figure 72. Biotechnological Drugs Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
